Literature DB >> 3368910

[The use of a beta 2-mimetic agent (clenbuterol) in equine pregnancy disorders and obstetrics].

H Bostedt1.   

Abstract

A clinical study about the effects of a beta 2-mimetic agent (Clenbuterol) in mares with pregnancy disorders or disorders during the periparturient period (n = 34) is reported. In general, a single dose of 0.3 mg Clenbuterol given i.v. induces sufficient tocolysis. Subsequent doses or follow-up treatment depend upon individual development during dystocia, indication of treatment and clinical preparturient status (dorsoflexio uteri ante partum, abortus imminens, preparturient labor pains).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368910

Source DB:  PubMed          Journal:  Tierarztl Prax        ISSN: 0303-6286


  2 in total

1.  Epidemiologic study of an outbreak of clenbuterol poisoning in Catalonia, Spain.

Authors:  L Salleras; A Domínguez; E Mata; J L Taberner; I Moro; P Salvà
Journal:  Public Health Rep       Date:  1995 May-Jun       Impact factor: 2.792

2.  The use of clenbuterol in large animal obstetrics: manual correction of bovine dystocias.

Authors:  L Ménard
Journal:  Can Vet J       Date:  1994-05       Impact factor: 1.008

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.